David Landsberg

TL;DR: MMF is associated with a significantly lower rate of treatment failure compared with AZA during the first 6 months after renal transplantation and produces a clinically important reduction in the incidence, severity, and treatment of acute graft rejection.

TL;DR: The number of new patients with the disease increased at a compound annual rate of 7.3% from 1981 to 1999, and similar trends have been documented worldwide.

TL;DR: The findings do not support limiting access to transplantation for otherwise suitable candidates on the basis of longer anticipated waiting times, and all subjects derived a survival benefit from transplantation with waiting times up to 3 years.

TL;DR: MeCsA appears to be a safe and effective therapy in stable renal transplant patients and provides superior and more consistent absorption of cyclosporine when compared with ConCsA, a prospective, randomized, concentration-controlled, pharmacoepidemiologic study.

TL;DR: Content analysis of motivations showed that potential LADs were more likely than non‐LADs (those who did not pass the criteria) to have a spiritual belief system and to be altruistic, and non‐CPSI participants were more than twice as likely to use donation to make a statement against their families.